HRT Financial’s Evotec EVO Stock Holding History

HRT Financial’s Portfolio EVO Stock Details EVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,510	Closed	-$26K	–	4545
2026 Q1	$26K	Sell	10,510 -12,961	-55%	-$41.8K	﹤0.01%	3540
2025 Q4	$72K	Buy	+23,471	New	+$80.5K	﹤0.01%	2834

Other funds holding EVO

DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

Fore Capital New York $338M AUM 10.07% 1-Year Est. Return

HRT Financial's EVO Position: Q2 2026 in Review

HRT Financial sold out of Evotec (EVO) in Q2 2026, closing a stake of 10,510 shares — an estimated $26K sold.

HRT Financial first reported a position in EVO in Q4 2025 and held it in 2 quarters. The position peaked at $72K in Q4 2025. 34 funds tracked by Wall St. Rank hold EVO as of Q2 2026.

HRT Financial reported no remaining Evotec position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 10,510 Evotec shares in Q2 2026, an estimated $26K.
HRT Financial first reported a position in Evotec in Q4 2025 and held it in 2 quarters.
HRT Financial's Evotec position peaked at $72K in Q4 2025.
34 funds tracked by Wall St. Rank held Evotec as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.